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Hydroxyapatite (HA) ceramics are widely used for bone reconstruction. They are
osteoconductive and serve as structural scaffolds for the deposition of new bone.
Generally, scaffold materials should be degradable as they affect the mechanical
properties of the reconstructed bone negatively. Degradation by osteoclasts
during the bone remodelling process is desirable but often does not take place.
In the current study we analysed by light microscopy the degradation of two
granular HA implants in critically sized defects in the mandibula of Goettingen
mini-pigs five weeks after implantation. Bio-Oss® consists of sintered bovine
bone and NanoBone® is a synthetic HA produced in a sol-gel process in the
presence of SiO2. We found that both biomaterials were degraded by osteo-
clasts with ruffled borders and acid phosphatase activity. The osteoclasts creat-
ed resorption lacunae and resorptive trails and contained mineral particles. Fre-
quently, resorption surfaces were in direct contact with bone formative surfaces
on one granule. Granules, especially of NanoBone®, were also covered by os-
teoclasts if located in vascularised connective tissue distant from bone tissue.
However, this usually occurred without the creation of resorption lacunae. The
former defect margins consisted of newly formed bone often without remnants
of bone substitutes. Our results show that the degradation of both biomaterials
corresponds to the natural bone degradation processes and suggest the possi-
bility of complete resorption during bone remodelling.
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INTRODUCTION
The high incidence of morbidity during autoge-
nous bone grafting has been the rationale for the
increase in applications of bone substitute materials.
Hydroxyapatite (HA) ceramics, produced synthetically
or by processing biological substrates, have been
widely and successfully used for bone reconstruc-
tion. They are available as granules, as blocks with
pores of different sizes or as injectable material. In
any case, owing to its osteoconductive capacity, HA
serves as a structural scaffold for the building of new
bone tissue. The scaffold itself should be completely
degradable, as remnants could affect the mechani-
cal properties of reconstructed bone negatively and,
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as non-self, may induce inflammation. It is desirable
for scaffold degradation to take place during the
regular bone remodelling processes [28]. The extent
and distribution of the remodelling of bone substi-
tutes are influenced by the quality of the host site
and the local mechanical environment [2]. Particles
of HA ceramics are often detectable in patients even
years after implantation.
The biodegradation of HA scaffolds may take
place by dissolution or fragmentation with subse-
quent phagocytosis by macrophages [8] but also by
the activity of osteoclasts [6, 25, 34]. The latter mech-
anism of biodegradation is favourable [30], because
mimicry of the physiological bone processes should
create optimal surfaces for colonisation with osteo-
blasts and vascular tissue. The degree of osteoclast
activity on HA scaffolds depends on material quali-
ties such as crystal size [6, 23, 25] and surface rough-
ness [14]. Macrocrystalline HA is not degradable by
osteoclasts [24, 32], but microcrystalline HA may also
escape resorption, if the biomaterials were sintered
during production [26].
We studied the cellular biodegradation of two
granular microcrystalline HA implants in critically
sized defects in the mandibula of Goettingen minia-
ture pigs. Bio-Oss® is an HA ceramic produced by
sintering bovine spongious bone and is extensively
used as a bone substitute. NanoBone® is a synthetic
HA with nano- and micropores manufactured in
a sol-gel process in the presence of SiO2 [12]. It has
been available commercially since 2005. Using light
microscopy we made a comparative analysis of the
distribution and activities of osteoclastic cells on
these biomaterials five weeks after implantation.
MATERIAL AND METHODS
Animals
Six adult Goettingen miniature pigs (Ellgaard,
Dalmose, Denmark) of 25–30 kg body weight were
used in this study. The animals were kept free in an
appropriate facility. Standard mini-pig diet and tap
water were available ad libitum. The animals were
handled in agreement with the European Commu-
nities Council Directive of November 24, 1986. The
experiments were performed with the permission of
the local ethics committee.
Grafting materials
Bio-Oss® (Geistlich-Pharma, Wolhusen, Switzer-
land) is a sintered HA ceramic derived from depro-
teinised bovine spongious bone and was used as
granules of 1–2 mm diameter. NanoBone® (Artoss
GmbH, Rostock, Germany) contains 74% unsintered HA
and 24% SiO2 and is manufactured in a sol-gel
process. It was used as granules measuring about
0.6 × 2 mm.
Critically sized defects and
insertion of biomaterials
Bone perforating critically sized defects (about
3 × 1.5 × 1.3 cm; > 5 cm3) were placed bilaterally
in the anterior part of the corpus mandibulae basal
to the teeth, leaving the lingual periosteum intact.
The defects were filled with the biomaterial mixed
with blood (N = 3 animals per tested material) and
closed with the vestibular periosteum and skin. For
further details and for handling of the animals dur-
ing surgery see Henkel et al. [16].
The animals were killed by an intracardial injec-
tion of pentobarbital five weeks post operationem.
Histological analysis
The defects were fixated in toto in 4% buffered
formaldehyde for a minimum of 7 days before cut-
ting transversally into 4 mm thick blocks. Undecalci-
fied blocks were embedded in methacrylate resins
(Technovit 7200 VLC, Technovit 9100NEW, Kultzer & Co,
Wehrhein, Germany) for the sawing-grinding tech-
nique [9] and the preparation of thin sections. Sam-
ples decalcificated with EDTA were embedded in
paraffin. Sections were stained with haematoxylin
& eosin (HE), toluidine blue, Giemsa, Goldner’s
trichrome or silver nitrite (von Kossa stain). Evalua-
tion of tartrate-resistant acid phosphatase (TRAP)
activity was made with naphthol AS-BI phosphate
and pararosaniline.
For the microscopic evaluation we used a photo-
microscope (Axioplan, Zeiss, Germany) and the soft-
ware Analysis® (Soft Imaging Systems, Münster, Ger-
many).
RESULTS
General findings
With one exception, there was a complete bridg-
ing of the lingual wall of the defects by newly formed
bone tissue surrounding granules of the biomateri-
als (Fig. 1A). The new bone was compact, but locally
cancellous. Remodelling was evident as young os-
teons with large vascular channels embedded in
woven bone. The peripheral parts of the former de-
fects consisted of new bone with only minimal bio-
material remnants or none at all (Fig. 1B).
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The vestibular wall of the defects was bridged by
thin trabeculae of woven bone contacting granules
of biomaterial surrounded mainly by connective tis-
sue. In the centre of the defects these walls con-
tained only connective tissue and biomaterial. The
region of the former canalis mandibularis consisted
partly of osseous trabeculae but mainly of connec-
tive tissue and granules.
Figure 1. Light microscopy of bone defects in the mandibula of mini-pigs five weeks after implantation of bone substitute materials.
A. Lingual the centre of a defect filled with NanoBone® is bridged with bone surrounding NanoBone® granules (stars). Bone and granules
are in the process of remodelling. B. Margin of a former defect displaying small remnants of Bio-Oss® (stars). C., D. Osteoclasts with
visible ruffled borders (arrows) are situated in resorption lacunae of bone (C) and Bio-Oss® (D). E., F. High numbers of osteoclasts attach
to surface and to formerly vascular channels (stars in E) of Bio-Oss® granules located near bone. They may also form resorptive trails
(star in F). Thick plastic sections, toluidine blue. Scale bars are given in the lower right corner of the micrographs.
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Degradation of NanoBone®
and Bio-Oss® implants
In all the histological samples analysed multinu-
clear cells attached to the surface of biomaterial gran-
ules were observed. These had the same shape and
size as osteoclasts adhering to bone tissue (Fig. 1C, D).
Most of these cells demonstrated the features of
osteoclasts such as polarisation, ruffled border and
TRAP activity (Fig. 1D; 2A, C). Signs of osteoclastic
resorption of the biomaterials were evident as re-
sorption lacunae on the granule surface (Fig. 1C, F;
2A, C) and, in the case of Bio-Oss®, in the formerly
vascular osteon channels of this bovine biomaterial
(Fig. 1E). The dimensions of the lacunae correspond-
ed to those on bone surfaces in our samples. How-
ever, the proportion of osteoclasts lying in erosion
lacunae was smaller than in bone tissue. There was
also evidence of resorptive trail formation in Nano-
Bone® (Fig. 2C) as well as in Bio-Oss® (Fig. 1F). In Bio-
Oss® this was identified by osteoclasts situated in
channels not surrounded by bone lamellae (Fig. 1F).
The cytoplasm of osteoclasts located on bioma-
terial often contained differently sized vacuoles and
particles stained with toluidine blue, Goldner’s
trichrome and von Kossa (Fig. 2A, C, D). Such particles
were also found near the free surfaces of these cells.
Osteoclasts attached to biomaterial were regu-
larly found in areas with new formation of bone
and remodelling respectively, though not on all gran-
ules. Frequently bone formation and resorption of
the biomaterial proceeded in direct continuity on
the granules (Fig. 1F; 2A). Osteoclasts attached to
granules also occurred in defect regions without vis-
ible bone formation. This was true especially for
NanoBone® implants, where granules in the con-
nective tissue were often completely surrounded
Figure 2. Light microscopy of bone defects in the mandibula of mini-pigs five weeks after implantation of NanoBone®. A. Bone deposi-
tion (white arrowheads) and osteoclastic resorption (black arrowheads) proceed in direct continuity on a granule. B. Granules surround-
ed only by connective tissue may be covered with TRAP-active osteoclasts but rarely show resorption lacunae. C. Osteoclasts contain-
ing particles and demonstrating ruffled borders (arrows) are attached to a granule. D. The particles in the cytoplasm of osteoclasts (ar-
rows) are stainable with Goldner’s trichrome and von Kossa staining (inset). A., C. Thick plastic sections, toluidine blue. B. Paraffin
section, TRAP activity. D. Thin plastic sections, Goldner’s trichrome and von Kossa (inset) respectively. Scale bars are given in the lower
right corner of the micrographs.
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by multinuclear cells. These cells were TRAP-reactive,
but rarely situated in resorption lacunae. Large multi-
nuclear cells without the features of osteoclasts only
occasionally contacted granules of either biomaterial.
DISCUSSION
In the experimental design used for this study
we were able to demonstrate that two bone replace-
ment materials based on hydroxyapatite are degrad-
ed by osteoclasts. The periphery of the former de-
fects consisted of newly formed bone without bio-
material residues, demonstrating that complete bio-
degradation of the tested materials is possible.
Concerning NanoBone®, this confirms the results of
other studies carried out with the same animal
model [3, 15, 27], which have reported only small
amounts of the material eight months after implan-
tation. The fast, extensive degradation of Nano-
Bone® is explained by a high degree of nano- and
microporosity and a loose arrangement of small HA
crystals [12], physical properties that promote deg-
radation [11, 13, 18, 19, 24].
Concerning the biodegradation of Bio-Oss®, opi-
nions in the literature vary but the prevalent view is
of resorbability [10]. However, Duda and Pajak [10],
amongst others, have observed Bio-Oss® remnants
in patients even years after implantation. Experiments
performed in the cranial bones of dogs [22, 31] could
not demonstrate signs of biodegradation after sev-
eral months, while in goats degradation by osteo-
clast-like cells was found [21]. A recent human
study [35] also reports degradation by osteoclasts.
The reasons for the conflicting results may lie in fac-
tors such as animal model, implantation site and the
local mechanical environment, which influence the
remodelling of bone substitute materials [2, 20]. An
impressive example of the influence of mechanical
forces is described for orthodontic movements in the
dog, where 12 months after implantation Bio-Oss®
remained an inactive filler in non-utilised areas of
the mandibula but was extensively degraded in zones
with mechanical strain [1]. Such zones must be con-
stantly remodelled and we found osteoclasts resorb-
ing biomaterial predominantly in defect areas with
extensive bone remodelling. During the remodelling
processes osteoclasts form channels in the first, rap-
idly formed woven bone, which are filled by vascu-
larised connective tissue. To the extent that these
channels come into contact with biomaterial, osteo-
clast progenitor cells may attach to the granules and
differentiate to active cells. In our study degrada-
tion was characterised by resorption pits and trails
in HA granules, but also by small mineral parti-
cles within and near the attached osteoclasts. Thus
the removal of biomaterial resorption products by
osteoclasts seems to follow the mechanisms
demonstrated for bone [29]. That osteoclasts si-
multaneously resorb and phagocytise calcium
phosphate ceramics was demonstrated by trans-
mission electron microscopy in vitro [7, 17, 39]
and in vivo [34]. We found evidence, as did We-
nisch et al. [34], that material released into the
extracellular space can then be phagocytised by
mononuclear macrophages.
Osteoclasts were also attached to granules situ-
ated in vascularised connective tissue in areas with-
out bone formation (a defect centre on the vestibu-
lar side). We observed this especially after implanta-
tion of NanoBone®. This reflects the situation in nat-
ural bone, where the arrival of osteoclasts is trig-
gered by bare mineralised bone surfaces created by
the activity of collagenases [5]. However, on Nano-
Bone® embedded in connective tissue osteoclasts
were rarely situated in resorption lacunae. This sug-
gests that activating signals [4] are lacking in these
regions. For the maintenance of the scaffold func-
tion of bone substitutes the inactivity of osteoclasts
on biomaterial in areas without bone formation is
imperative.
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